Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
Add more filters










Publication year range
1.
Pharmacol Ther ; 130(3): 338-47, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21356241

ABSTRACT

The 5-Hydroxytryptamine3 (5-HT3) receptor is a member of the cys-loop family of ligand gated ion channels, of which the nicotinic acetylcholine receptor is the prototype. All other 5-HT receptors identified to date are metabotropic receptors. The 5-HT3 receptor is present in the central and peripheral nervous systems, as well as a number of non-nervous tissues. As an ion channel that is permeable to the cations, Na(+), K(+), and Ca(2+), the 5-HT3 receptor mediates fast depolarizing responses in pre- and post-synaptic neurons. As such, 5-HT3 receptor antagonists that are used clinically block afferent and efferent synaptic transmission. The most well established physiological roles of the 5-HT3 receptor are to coordinate emesis and regulate gastrointestinal motility. Currently marketed 5-HT3 receptor antagonists are indicated for the treatment of chemotherapy, radiation, and anesthesia-induced nausea and vomiting, as well as irritable bowel syndrome. Other therapeutic uses that have been explored include pain and drug addiction. The 5-HT3 receptor is one of a number of receptors that play a role in mediating nausea and vomiting, and as such, 5-HT3 receptor antagonists demonstrate the greatest anti-emetic efficacy when administered in combination with other drug classes.


Subject(s)
Receptors, Serotonin, 5-HT3/metabolism , Serotonin 5-HT3 Receptor Antagonists/therapeutic use , Animals , Forecasting , Gastrointestinal Motility/drug effects , Gastrointestinal Motility/physiology , Humans , Irritable Bowel Syndrome/drug therapy , Irritable Bowel Syndrome/metabolism , Nausea/drug therapy , Nausea/metabolism , Serotonin 5-HT3 Receptor Antagonists/pharmacology , Vomiting/drug therapy , Vomiting/metabolism
2.
Biochemistry ; 48(39): 9278-86, 2009 Oct 06.
Article in English | MEDLINE | ID: mdl-19715355

ABSTRACT

A HEK-293 cell line that stably expresses mouse 5-HT(3A)Rs containing a C-terminal extension that confers high-affinity binding of alpha-bungarotoxin (alphaBgTx) was established (alphaBgTx-5-HT(3A)Rs) and used to purify alphaBgTx-5-HT(3A)Rs in a lipid environment for use in structural studies using photoaffinity labeling. alphaBgTx-5-HT(3A)Rs were expressed robustly (60 pmol of [(3)H]BRL-43694 binding sites (approximately 3 microg of receptor) per milligram of protein) and displayed the same functional properties as wild-type receptors (serotonin EC(50) = 5.3 +/- 0.04 microM). While [(125)I]alphaBgTx bound to the alphaBgTx-5-HT(3A)Rs with high affinity (K(d) = 11 nM), application of nonradioactive alphaBgTx (up to 300 microM) had no effect on serotonin-induced current responses. alphaBgTx-5-HT(3A)Rs were purified on an alphaBgTx-derivatized affinity column from detergent extracts in milligram quantities and at approximately 25% purity. The hydrophobic photolabel 3-trifluoromethyl-3-(m-[(125)I]iodophenyl)diazirine ([(125)I]TID) was used to identify the amino acids at the lipid-protein interface of purified and lipid-reconstituted alphaBgTx-5-HT(3A)Rs. [(125)I]TID photoincorporation into the alphaBgTx-5-HT(3A)R subunit was initially mapped to subunit proteolytic fragments of 8 kDa, containing the M4 transmembrane segment and approximately 60% of incorporated (125)I, and 17 kDa, containing the M1-M3 transmembrane segments. Within the M4 segment, [(125)I]TID labeled Ser(451), equivalent to the [(125)I]TID-labeled residue Thr(422) at the lipid-exposed face of the Torpedo nicotinic acetylcholine receptor (nAChR) alpha1M4 alpha-helix. These results provide a first definition of the surface of the 5-HT(3A)R M4 helix that is exposed to lipid and establish that this surface is equivalent to the surface exposed to lipid in the Torpedo nAChR.


Subject(s)
Lipoproteins/metabolism , Photoaffinity Labels/metabolism , Receptors, Serotonin, 5-HT3/chemistry , Animals , Bungarotoxins/metabolism , Cell Line , Humans , Hydrophobic and Hydrophilic Interactions , Lipoproteins/chemistry , Mice , Receptors, Nicotinic/chemistry , Receptors, Nicotinic/metabolism , Receptors, Serotonin, 5-HT3/metabolism , Torpedo/metabolism
3.
Biochemistry ; 46(5): 1194-204, 2007 Feb 06.
Article in English | MEDLINE | ID: mdl-17260949

ABSTRACT

The competitive antagonist d-tubocurarine (curare) has greater potency at mouse than at human 5-hydroxytryptamine 3A (5-HT3A) receptors, despite 84% amino acid sequence identity between the receptors. Within the ligand binding domain of this receptor are six loops (A-F). A previous report demonstrated that loop C of the 5-HT3A receptor contributed to differential potency between the receptors [Hope, A. G. et al. (1999) Mol. Pharmacol. 55, 1037-1043]. The present study tested the hypothesis that loop F plays a significant role in conferring interspecies curare potency differences. Wild-type, chimeric, and point mutant 5-HT3A receptors were expressed in Xenopus oocytes, and two-electrode voltage clamp electrophysiological recordings were performed. Our data suggest that loops C and F contribute to curare potency, given that the curare IC50's (concentration of drug that produces 50% inhibition of the response) for chimeric human receptors with substitutions of mouse residues in loop C (40.07 +/- 2.52 nM) or loop F (131.8 +/- 5.95 nM) were intermediate between those for the mouse (12.99 +/- 0.77 nM) and human (1817 +/- 92.36 nM) wild-type receptors. Two human point mutant receptors containing mouse receptor substitutions in loop F (H-K195E or H-V202I) had significantly lower curare IC50's than that of the human receptor. The human double mutant receptor, H-K195E,V202I, had the same curare IC50 (133.8 +/- 6.38 nM) as that of the human receptor containing all six loop F mouse substitutions. These results demonstrate that two loop F residues make a significant contribution in determining curare potency at the 5-HT3A receptor.


Subject(s)
Receptors, Serotonin/drug effects , Tubocurarine/pharmacology , Amino Acids , Animals , Binding Sites/genetics , Electrophysiology , Humans , Inhibitory Concentration 50 , Mice , Neuromuscular Nondepolarizing Agents/pharmacology , Oocytes , Point Mutation , Receptors, Serotonin/genetics , Receptors, Serotonin, 5-HT3 , Species Specificity , Transduction, Genetic , Xenopus
4.
Brain Res ; 1086(1): 1-8, 2006 May 01.
Article in English | MEDLINE | ID: mdl-16626662

ABSTRACT

Amphibian oocyte and mammalian heterologous expression systems are often used to investigate the function of recombinant ion channels using electrophysiological techniques. Although both systems have yielded important information, the results obtained in these systems are sometimes conflicting. Oocytes and mammalian cells differ in their physiological temperature requirements. While room temperature is within the physiological temperature range for oocytes, this temperature is far below that required by mammalian cells. Since electrophysiological studies are often performed in both oocytes and mammalian cells at room temperature, we sought to determine if recording temperature could be a factor in some disparate results obtained in these cell types. For these studies, we examined phorbol ester modulation of GABA(A) and glycine receptors. Consistent with the literature, at room temperature, PMA (phorbol 12-myristate 13-acetate) produced a large reproducible decrease in the peak amplitude of GABA and glycine-gated currents in Xenopus oocytes. In contrast, PMA was ineffective in modulating these heterologously expressed receptors at room temperature in human embryonic kidney (HEK) 293 cells. However, when electrophysiological experiments were performed at 35 degrees C in HEK 293 cells, PMA decreased the function of these receptors. Our results indicate that the temperature at which electrophysiological studies are conducted is an important experimental variable. To determine the extent to which electrophysiological recordings are performed at physiological temperatures in HEK 293 cells, a PubMed search was conducted using the search terms "patch clamp" and "HEK" for the years 2003-2004. This search revealed that only 15% of the patch clamp studies were reported to have been conducted in the temperature range of 32-37 degrees C. The results of our study indicate that temperature is an important experimental variable that requires rational consideration in the design of electrophysiological experiments.


Subject(s)
Ion Channel Gating/physiology , Membrane Potentials/physiology , Protein Kinase C/metabolism , Temperature , Analysis of Variance , Animals , Cell Line , Drug Interactions , Electric Stimulation/methods , Enzyme Activation/drug effects , Female , Glycine/pharmacology , Humans , Ion Channel Gating/drug effects , Ion Channel Gating/radiation effects , Membrane Potentials/drug effects , Membrane Potentials/radiation effects , Oocytes , Patch-Clamp Techniques/methods , Phorbol Esters/pharmacology , Receptors, GABA/physiology , Receptors, Serotonin/physiology , Serotonin/pharmacology , Transfection/methods , Xenopus , gamma-Aminobutyric Acid/pharmacology
5.
J Pharmacol Exp Ther ; 317(3): 1276-84, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16551836

ABSTRACT

The present study tested the hypothesis that mouse and human 5-hydroxytryptamine3A (5-HT3A) receptors may be differentially modulated by benzylidene analogs of anabaseine (BA) and that these analogs may be useful in assessing residues involved in receptor gating. Mouse and human wild-type and mouse and human chimeric 5-HT3A receptors expressed in Xenopus oocytes were evaluated with the two-electrode voltage clamp technique. Our previous studies demonstrated that 3-(2,4-dimethoxybenzylidene)-anabaseine (DMXBA) is an antagonist at the mouse wild-type 5-HT3A receptor, but that its metabolites 3-(2-hydroxy, 4-methoxybenzylidene)-anabaseine (2-OHMBA), 3-(2-methoxy, 4-hydroxybenzylidene)-anabaseine (4-OHMBA), and 3-(2,4-dihydroxybenzylidene)-anabaseine (2,4-DiOHBA) are partial agonists (J Pharmacol Exp Ther, 299: 1112-1117, 2001). In the human wild-type (HWT) 5-HT3A receptor, none of the BA compounds possessed partial agonist activity. BA compounds antagonized 1.5 microM 5-HT-mediated (EC50) responses in the HWT 5-HT3A receptor with a rank order of potency (IC50 in muM) of 2-OHMBA (1.5 +/- 0.1) > DMXBA (3.1 +/- 0.2) > 4-OHMBA (7.4 +/- 0.5) > 2,4-DiOHBA (12.8 +/- 0.7). In mouse receptor chimeras containing N-terminal human receptor orthologs, 2-OHMBA inhibited 5-HT-mediated (EC50) currents with IC50 values of 2.0 +/- 0.08 and 3.0 +/- 0.13 microM, respectively. In human receptor chimeras containing N-terminal mouse receptor orthologs, 2-OHMBA displayed partial agonist activities with EC50 values of 1.3 +/- 0.15 and 5.0 +/- 0.4 microM; efficacies were 43 and 57%, respectively. Thus, amino acids present in the distal one-third of the N terminus of mouse and human 5-HT3A receptors are necessary and sufficient to confer partial agonist or antagonist properties of 2-OHMBA.


Subject(s)
Anabasine/analogs & derivatives , Benzylidene Compounds/pharmacology , Receptors, Serotonin/metabolism , Serotonin Antagonists/pharmacology , Serotonin Receptor Agonists/pharmacology , Anabasine/chemistry , Anabasine/pharmacology , Animals , Benzylidene Compounds/chemistry , Cloning, Molecular , Humans , Mice , Molecular Structure , Oocytes/metabolism , Patch-Clamp Techniques , Protein Structure, Tertiary , Receptors, Serotonin/chemistry , Receptors, Serotonin/genetics , Receptors, Serotonin, 5-HT3 , Serotonin Antagonists/chemistry , Serotonin Receptor Agonists/chemistry , Xenopus laevis
6.
Biochemistry ; 45(13): 4327-37, 2006 Apr 04.
Article in English | MEDLINE | ID: mdl-16566607

ABSTRACT

The lipid requirements of the Torpedo californica nicotinic acetylcholine receptor (nAChR) were assessed by reconstituting purified receptors into lipid vesicles of defined composition and by using photolabeling with 3-trifluoromethyl-3-(m-[125I]iodophenyl)diazirine ([125I]TID) to determine functionality. Earlier studies demonstrated that nAChRs reconstituted into membranes containing phosphatidylcholine (PC), the anionic lipid phosphatidic acid (PA), and cholesterol (CH) are particularly effective at stabilizing the nAChR in the resting (closed) state that is capable of undergoing agonist-induced conformational transitions (i.e., functionality). The present studies demonstrate that (1) there is no obligatory requirement for PC, (2) increasing the CH content serves to increase the degree to which nAChRs are stabilized in the resting state, and this effect saturates at approximately 35 mol % (molar lipid percentage), and (3) the effect of increasing levels of PA saturates at approximately 12 mol % and in the absence of PA nAChRs are stabilized in the desensitized state (i.e., nonfunctional). Native Torpedo membranes contain approximately 35 mol % CH but less than 1 mol % PA, suggesting that other anionic lipids may substitute for PA. We report that (1) phosphatidylserine (PS) and phosphatidylinositol (PI), anionic lipids that are abundant in native Torpedo membranes, also stabilize the receptor in the resting state although with reduced efficacy (approximately 50-60%) compared to PA, and (2) for nAChRs reconstituted into PA/CH membranes at different lipid-protein molar ratios, receptor functionality decreases rapidly below approximately 65 lipids per receptor. Collectively, these results are consistent with a functional requirement of a single shell of lipids surrounding the nAChR and specific anionic lipid- and sterol (CH)-protein interactions.


Subject(s)
Membrane Lipids/chemistry , Receptors, Nicotinic/chemistry , Animals , Azirines , Cholesterol/chemistry , Electrophoresis, Polyacrylamide Gel , Liposomes/chemical synthesis , Phosphatidic Acids/chemistry , Phosphatidylinositols/chemistry , Phosphatidylserines/chemistry , Torpedo
7.
Br J Pharmacol ; 148(1): 88-101, 2006 May.
Article in English | MEDLINE | ID: mdl-16520747

ABSTRACT

1 The goal of this study was to determine whether mutations of L293 at the 15' position of TM2 in the 5-HT(3A) receptor alter macroscopic current kinetics, and if these changes could account for alterations in alcohol modulation. Receptor function was assessed in Xenopus oocytes under voltage-clamp and in HEK293 cells with whole-cell patch-clamp recording and rapid drug application. 2 Examination of responses of L293C and L293S receptors to agonist alone revealed enhanced activation, deactivation, and desensitization rates relative to the wild-type receptor. The L293G mutation produced marked slowing of deactivation and desensitization rates. Increased potency of 5-HT and increased efficacy of the partial agonist, DA, was also observed in these mutant receptors. 3 Ethanol and trichloroethanol (TCEt) enhancement of receptor function was reduced or eliminated in receptors containing L293 mutations to C, G, or S. The L293I mutant receptor retained ethanol and TCEt sensitivity. Ethanol and TCEt enhanced activation rate in the wild-type, but not the L293G and L293S receptors. No relationship was observed between any physicochemical property of the substituted amino acids and the change in alcohol potentiation of function. 4 The changes in receptor-channel properties in the mutant receptors support the idea that the L293 residue has important roles in channel gating. Our findings indicate that loss of allosteric modulation by alcohols is not related in any simple way to changes in channel kinetic properties brought about by L293 mutants. We did not observe any evidence that L293 is part of an alcohol binding site.


Subject(s)
Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Ethylene Chlorohydrin/analogs & derivatives , Ion Channel Gating , Receptors, Serotonin/drug effects , Allosteric Regulation , Animals , Cell Line , Dopamine , Dose-Response Relationship, Drug , Ethylene Chlorohydrin/pharmacology , Humans , Kinetics , Lysine/genetics , Membrane Potentials , Mice , Mutation , Oocytes/metabolism , Patch-Clamp Techniques , Protein Structure, Tertiary , Receptors, Serotonin/genetics , Receptors, Serotonin/metabolism , Receptors, Serotonin, 5-HT3 , Serotonin , Transfection , Xenopus laevis
8.
Alcohol Clin Exp Res ; 30(2): 349-58, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16441284

ABSTRACT

This report of the proceedings of a symposium presented at the 2005 annual meeting of the Research Society on Alcoholism highlights the actions of ethanol on purinergic (P2XRs) and 5-hydroxytryptamine3 (5-HT3Rs) receptors. Both P2XRs and 5-HT3Rs, are modulated by pharmacologically relevant concentrations of ethanol, with inhibition or stimulation of P2XR subtypes and stimulation of 5-HT3Rs, respectively. With regard to ethanol-modulatory actions, these 2 distinctly different receptor classes have been studied to a much lesser extent than other LGICs. The organizers and chairs were Daryl L. Davies and Tina K. Machu. John J. Woodward discusses the molecular pharmacology and physiology of P2XRs and 5-HT3Rs and sets the stage for a detailed investigation into the ethanol sensitivity of these channels by the invited speakers. Daryl L. Davies discusses the results from recent electrophysiological studies conducted in his and Dr. Woodward's laboratories, highlighting the actions of ethanol on P2XR subtypes. Jiang-Hong Ye discusses results from recent studies using loose-patch and whole-cell recordings on purinergic receptors expressed on neurons from the ventral tegmental area (VTA) in rats. Tina K. Machu discusses electrophysiological studies conducted in her and Dr. David Lovinger's laboratories on nonpore lining residues of the second transmembrane domain (TM2) of the 5-HT3A receptor. Li Zhang presents data demonstrating that F-actin cytoskeletons play a critical role in 5-HT3 receptor clustering in hippocampal neurons. Collectively, the presentations provided strong evidence that P2X and 5-HT3 receptors are important targets for ethanol action.


Subject(s)
Brain/drug effects , Ethanol/pharmacology , Receptors, Purinergic P2/drug effects , Receptors, Serotonin, 5-HT3/drug effects , Animals , Hippocampus/drug effects , Humans , Membrane Potentials/drug effects , Neurons/drug effects , Rats , Receptors, Purinergic P2X , Stimulation, Chemical , Ventral Tegmental Area/drug effects
9.
Brain Res Mol Brain Res ; 142(2): 146-50, 2005 Dec 14.
Article in English | MEDLINE | ID: mdl-16257471

ABSTRACT

Allosteric modulation of mouse 5-Hydroxytryptamine(3A) (5-HT(3A)) and 5-HT(3A/B) receptor function by ethanol and trichloroethanol (TCEt) was assessed in HEK293 cells with whole cell patch-clamp electrophysiological recordings. Ethanol enhanced 5-HT(3A) receptor function, but had no effect on mouse 5-HT(3A/B) receptor mediated currents. The enhancing action of trichloroethanol (TCEt) on mouse 5-HT(3A/B) receptor function was much less than that observed in the mouse 5-HT(3A) receptor. Where alcohol-induced increases in peak amplitude were observed, the slope of the 20-80% rising phase of current onset was also enhanced, suggesting that increases in activation rate may be one mechanism through which alcohols enhance function of the 5-HT(3) receptors.


Subject(s)
Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Gene Expression/drug effects , Receptors, Serotonin, 5-HT3/metabolism , Animals , Cell Line , Dose-Response Relationship, Drug , Electric Stimulation/methods , Ethylene Chlorohydrin/analogs & derivatives , Ethylene Chlorohydrin/pharmacology , Humans , Membrane Potentials/drug effects , Membrane Potentials/physiology , Membrane Potentials/radiation effects , Mice , Patch-Clamp Techniques/methods , Protein Subunits/genetics , Protein Subunits/metabolism , Receptors, Serotonin, 5-HT3/genetics , Serotonin/pharmacology , Transfection/methods
10.
J Pharmacol Exp Ther ; 306(2): 595-604, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12730353

ABSTRACT

Mutant 5-hydroxytryptamine (5-HT)3A receptors, in which changes were made at Ile294, position 16', of the second transmembrane domain, were assessed for alterations in macroscopic response kinetics and modulation by alcohols. Function of heterologously expressed receptors was measured in Xenopus oocytes in the two-electrode voltage clamp configuration and in human embryonic kidney 293 cells using whole cell patch-clamp electrophysiological recordings with rapid drug application. Compared with the wild-type receptor, a decrease in the 5-HT EC50 value in the Ile294Thr mutant was observed, whereas an increase in the 5-HT EC50 value in the Ile294Leu mutant was measured. Ile294Thr receptors showed a marked reduction in the extent of desensitization. Ethanol and 2,2,2-trichloroethanol (TCEt) enhanced 5-HT-mediated currents in wild-type and Ile294Leu receptors, but inhibited or had little stimulatory effect in the Ile294Thr mutant. Kinetic analysis revealed that in the presence of TCEt, the slope of activation was unchanged in the Ile294Thr mutant and increased in the wild-type receptor. Alcohol cutoff was altered with wild-type = heptanol and Ile294Leu = hexanol. Kinetic changes in the Ile294Thr mutant that favor the open channel state, as well as reduction in the rate of channel activation in the presence of TCEt, likely underlie this mutant's altered response to n-chain alcohols.


Subject(s)
Ethanol/pharmacology , Receptors, Serotonin/metabolism , Serotonin/metabolism , Cells, Cultured , Electrophysiology , Humans , Membrane Proteins/genetics , Membrane Proteins/metabolism , Mutagenesis, Site-Directed , Patch-Clamp Techniques , Protein Structure, Tertiary/genetics , Receptors, Serotonin/drug effects , Receptors, Serotonin/genetics , Receptors, Serotonin, 5-HT3
11.
Recept Channels ; 8(2): 63-70, 2002.
Article in English | MEDLINE | ID: mdl-12448787

ABSTRACT

The effects of phorbol 12-myristate, 13-acetate (PMA) on 5-hydroxytryptamine (5-HT)-evoked ion currents in the mouse 5-HT3A receptor were examined. Perfusion with PMA caused a concentration dependent potentiation of 5-HT mediated currents and increased both potency and efficacy of 5-HT at the 5-HT3A receptor expressed in Xenopus oocytes. Enhancement of receptor function was partially blocked by injection of oocytes with PKCI, the peptide inhibitor of protein kinase C (PKC). Mutation of all 12 intracellular serine and threonine residues to alanine was without effect on PMA-induced potentiation of 5-HT elicited currents. Mutation of tyrosine 458 in the 5-HT3A receptor lacking intracellular serines and threonines reduced the PMA-induced potentiation of 5-HT evoked currents by approximately 55%. In contrast, mutation of tyrosine 458 in the wild-type receptor did not alter PMA-induced enhancement. The tyrosine kinase inhibitor, lavendustin A, reduced the enhancement of 5-HT3A receptor mediated currents by PMA in the mutant 5-HTA3A receptor containing no intracellular serine or threonine residues, but not in the wild-type receptor. Thus, the role of intracellular serines and threonines is redundant with that of tyrosine, suggesting that these two components act through a similar pathway in response to PMA treatment.


Subject(s)
Protein Kinase C/metabolism , Protein-Tyrosine Kinases/metabolism , Receptors, Serotonin/drug effects , Receptors, Serotonin/metabolism , Tetradecanoylphorbol Acetate/pharmacology , Amino Acid Substitution , Animals , Base Sequence , DNA, Complementary/genetics , Enzyme Inhibitors/pharmacology , Female , In Vitro Techniques , Mice , Mutagenesis, Site-Directed , Oocytes/drug effects , Oocytes/metabolism , Protein Kinase C/antagonists & inhibitors , RNA, Complementary/genetics , Receptors, Serotonin/genetics , Receptors, Serotonin, 5-HT3 , Recombinant Proteins/drug effects , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Xenopus laevis
12.
Arch Biochem Biophys ; 400(2): 215-22, 2002 Apr 15.
Article in English | MEDLINE | ID: mdl-12054432

ABSTRACT

System A, the Na(+)-dependent amino acid transport activity, is encoded by the ATA2 gene and up-regulated following partial hepatectomy (PH), and its competitive inhibition interferes with liver regeneration. Rabbit polyclonal antibody was raised against a portion of the ATA2 gene product followed by immunodetection of ATA2 in isolated liver plasma membrane and lysate. The level of ATA2 increased in the plasma membrane following PH, while the relatively high quantity of ATA2 found in liver lysate remained constant. We also have shown that Northern analysis of steady-state ATA2 mRNA revealed no significant change following PH. These data show that ATA2-mediated transport is not regulated by the steady-state level of ATA2 mRNA but is regulated by the amount of ATA2 and redistribution to the plasma membrane. We hypothesize that ATA2 activity is regulated by recruitment of ATA2 protein from an intracellular compartment. In addition, the pattern of expression of System A activity in oocytes, transport kinetics, and sensitivity to chemical modification indicate the presence of a second System A isoform in liver that differs substantially from ATA2.


Subject(s)
Amino Acid Transport System A/metabolism , Amino Acids/metabolism , Cell Membrane/metabolism , Liver Regeneration/physiology , beta-Alanine/analogs & derivatives , Amino Acid Transport System A/genetics , Amino Acids/pharmacokinetics , Animals , Biological Transport/drug effects , Biological Transport/physiology , Cell Compartmentation/physiology , Cell Membrane/chemistry , Ethylmaleimide/pharmacology , Hepatectomy , Intracellular Fluid/metabolism , Male , Oocytes/metabolism , Protein Isoforms/genetics , Protein Isoforms/metabolism , Protein Transport/physiology , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/metabolism , Sodium/metabolism , Sulfhydryl Reagents/pharmacology , Xenopus laevis , beta-Alanine/metabolism
13.
Alcohol Clin Exp Res ; 26(6): 773-8, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12068244

ABSTRACT

BACKGROUND: P2X receptors are ligand-gated cation channels that are gated by synaptically released extracellular adenosine 5'-triphosphate (ATP). P2X receptors are inhibited by ethanol; however, few investigations have focused on ethanol's effects in P2X receptors. Recently, recombinant homomeric P2X4 receptors were reported to be sensitive to ethanol's inhibitory action, whereas recombinant P2X3 receptors were insensitive to ethanol. The two recombinant studies were conducted in different expression systems by using different techniques; therefore, questions remain. The present study tests the hypothesis that ethanol sensitivity in P2X receptors is subunit dependent. METHODS: The effects of ethanol (25-200 mM +/- ATP) on rat recombinant homomeric P2X2 and P2X4 receptors expressed in Xenopus oocytes were tested by using two-electrode voltage clamp techniques. RESULTS: Ethanol inhibited EC10 ATP-gated currents significantly less in P2X2 versus P2X4 receptors. A second study found that ethanol right-shifted the ATP concentration-response curve in P2X2 receptors, which significantly increased the EC50 for ATP without altering the Hill slope or maximal current response to ATP. These latter characteristics of ethanol action in P2X2 receptors agree with previous work in P2X4 receptors. There was no effect of ethanol when tested in the absence of ATP. CONCLUSION: The findings are the first to show (1) ethanol inhibition of ATP-activated currents on P2X2 receptors, (2) differences in ethanol sensitivity between homomeric P2X receptors when tested under matched conditions, and (3) evidence that suggests similar mechanisms of ethanol action for P2X2 and P2X4 receptors. These findings provide the first direct support for the hypothesis that ethanol sensitivity in P2X receptors is subunit dependent.


Subject(s)
Adenosine Triphosphate/pharmacology , Ethanol/pharmacology , Ion Channel Gating/drug effects , Receptors, Purinergic P2/physiology , Adenosine Triphosphate/physiology , Animals , Dose-Response Relationship, Drug , Female , Ion Channel Gating/physiology , Protein Subunits , Purinergic P2 Receptor Antagonists , Rats , Receptors, Purinergic P2X2 , Receptors, Purinergic P2X4 , Xenopus laevis
SELECTION OF CITATIONS
SEARCH DETAIL
...